Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: An open Belgian multicenter study
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 110, S49-S54
- https://doi.org/10.1016/0021-9150(94)05378-v
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A comparison of the bioavailability of standard or micronized formulations of fenofibrateCurrent Therapeutic Research, 1993
- Effect of Three Fibrate Derivatives and of Two HMG-CoA Reductase Inhibitors on Plasma Fibrinogen Level in Patients with Primary HypercholesterolemiaThrombosis and Haemostasis, 1993
- Review of European Clinical Experience with FenofibrateCardiology, 1989
- Comparative toxicity and safety profile of fenofibrate and other fibric acid derivativesThe American Journal of Medicine, 1987
- Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986